Hereditary haemorrhagic telangiectasia (HHT)
Hereditary haemorrhagic telangiectasia (HHT) is a genetic condition passed down through families that impacts the blood vessels. It is also referred to as Osler-Weber-Rendu syndrome. Individuals with HHT may have blood vessels that are improperly formed, leading to bleeding episodes due to arteriovenous malformations (AVMs). When these AVMs occur in areas such as the nasal passages or the gastrointestinal tract, they can result in frequent bleeding. This ongoing bleeding can contribute to anaemia and potentially lead to more severe complications. Symptoms typically emerge during childhood or adolescence, but they can begin at any stage of life.
Professionals who treat hereditary haemorrhagic telangiectasia (hht) (6)
Dr James Mackay
Consultant Clinical Genetic Oncologist
Professor Sanjay Sharma
Cardiology
Professor Gerald Carr-White
Cardiology
Dr Amanda Varnava
Cardiology
Professor Christoph Nienaber
Cardiology
Mr Vikas Acharya
Consultant Rhinologist, Facial Plastic and ENT Surgeon